119 related articles for article (PubMed ID: 37798818)
1. Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumors.
Coppin R; Martelli H; Chargari C; Sudour-Bonnange H; Orbach D; Vérité C; Pasquet M; Saumet L; Piguet C; Patte C; Guérin F; Faure-Conter C; Fresneau B
Pediatr Blood Cancer; 2023 Dec; 70(12):e30697. PubMed ID: 37798818
[TBL] [Abstract][Full Text] [Related]
2. Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Hou JY; Liu HC; Yeh TC; Sheu JC; Chen KH; Chang CY; Liang DC
Pediatr Neonatol; 2015 Oct; 56(5):301-6. PubMed ID: 25769700
[TBL] [Abstract][Full Text] [Related]
3. Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study.
Pavone R; Pacquement H; Pasquet M; Sudour-Bonnange H; Hameury F; Sarnacki S; Chastagner P; Faure-Conter C; Poirée M; Taque S; Patte C; Fresneau B
Int J Cancer; 2021 Nov; 149(9):1705-1712. PubMed ID: 34146403
[TBL] [Abstract][Full Text] [Related]
4. [Ovarian malignant tumours. Efficacy of germ cell and sex cord tumour treatment protocol in Poland].
Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):803-10. PubMed ID: 17317911
[TBL] [Abstract][Full Text] [Related]
5. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
[TBL] [Abstract][Full Text] [Related]
6. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Tscherry G; Jacky E; Jost LM; Stahel RA
Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
8. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.
Anthoney DA; McKean MJ; Roberts JT; Hutcheon AW; Graham J; Jones W; Paul J; Kaye SB
Br J Cancer; 2004 Feb; 90(3):601-6. PubMed ID: 14760371
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).
Malogolowkin MH; Krailo M; Marina N; Olson T; Frazier AL
Pediatr Blood Cancer; 2013 Oct; 60(10):1602-5. PubMed ID: 23703725
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Yolk Sac Tumors: Our Experiences and Results.
Yuan Z; Cao D; Yang J; Keng S; Huang H
Int J Gynecol Cancer; 2017 Sep; 27(7):1489-1493. PubMed ID: 30814243
[TBL] [Abstract][Full Text] [Related]
12. Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Lopes LF; Macedo CR; Aguiar Sdos S; Barreto JH; Martins GE; Sonaglio V; Milone M; Lima ER; Almeida MT; Lopes PM; Watanabe FM; D'Andrea ML; Pianovski MA; Melaragno R; Vianna SM; Moreira ME; Bruniera P; de Oliveira CZ
J Clin Oncol; 2016 Feb; 34(6):603-10. PubMed ID: 26729441
[TBL] [Abstract][Full Text] [Related]
13. Primary vaginal endodermal sinus tumor in infants and children: experience from a tertiary center.
Yin M; Yang J; Wang T; Li S; Zhang X
BMC Pediatr; 2022 Oct; 22(1):579. PubMed ID: 36207682
[TBL] [Abstract][Full Text] [Related]
14. [Testicular malignant tumours. Efficacy of germ cell and sex cord tumours treatment protocol in Poland].
Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
Med Wieku Rozwoj; 2006; 10(3 Pt 1):811-7. PubMed ID: 17317912
[TBL] [Abstract][Full Text] [Related]
15. Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
Faure-Conter C; Orbach D; Cropet C; Baranzelli MC; Martelli H; Thebaud E; Vérité C; Rome A; Fasola S; Corradini N; Rocourt N; Frappaz D; Kalfa N; Patte C
Pediatr Blood Cancer; 2014 Feb; 61(2):253-9. PubMed ID: 23940114
[TBL] [Abstract][Full Text] [Related]
16. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).
Rescorla F; Billmire D; Stolar C; Vinocur C; Colombani P; Cullen J; Giller R; Cushing B; Lauer S; Davis M; Hawkins E; Shuster J; Krailo M
J Pediatr Surg; 2001 Jan; 36(1):12-7. PubMed ID: 11150431
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
[TBL] [Abstract][Full Text] [Related]
18. Malignant sacrococcygeal germ cell tumors in children: a 30-year experience from a single institution.
Büyükpamukçu M; Varan A; Küpeli S; Ekinci S; Yalcin S; Kale G; Yalçin B; Kutluk T; Akyüz C
Tumori; 2013; 99(1):51-6. PubMed ID: 23549000
[TBL] [Abstract][Full Text] [Related]
19. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
Pinkerton CR; Pritchard J; Spitz L
J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
[TBL] [Abstract][Full Text] [Related]
20. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Mann JR; Pearson D; Barrett A; Raafat F; Barnes JM; Wallendszus KR
Cancer; 1989 May; 63(9):1657-67. PubMed ID: 2467734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
